ResumoComparar o tempo médio de retorno dos atletas ao esporte após lesão muscular aguda da coxa com hematoma que foi ou não puncionado.Estudo longitudinal de intervenção clínica, controlado e não randomizado, com participação de 20 atletas amadores e profissionais com lesão muscular aguda do tipo parcial moderada ou (sub)total na região da coxa, segundo a classificação do Consenso de Munique. Nove atletas foram incluídos no grupo intervenção e 11 no grupo controle. Os atletas do grupo intervenção foram submetidos a punção do hematoma e fisioterapia e os do grupo controle, apenas a fisioterapia. A variável tempo de retorno ao esporte foi analisada com o teste de Mann-Whitney e o nível de significância usado foi 95% (p < 0,05).A população estudada foi composta principalmente por homens, dos quais oito eram praticantes de esportes no nível amador. Três mulheres, das quais duas eram amadoras, foram incluídas no estudo. A média de idade dos participantes foi de 34,70 ± 12,79 anos. Houve 13 indivíduos com lesões na região posterior da coxa, cinco com lesões na região anterior e dois com lesões na região adutora. Considerando todas as lesões, o tempo médio de retorno ao esporte foi de 48,50 ± 27,50 dias no grupo intervenção. Já no grupo controle, esse intervalo foi de 102,09 ± 52,02 dias (p = 0,022).No presente estudo, a punção do hematoma muscular mostrou-se efetiva em abreviar o tempo de retorno ao esporte dos atletas com lesões musculares parciais moderadas e (sub)totais associadas a hematomas.
Abstract:Although many health professionals believe that exercise protects the athletes against thrombosis, it is discussed whether elite athletes are exposed to many thrombogenic acquired risk factors such as: dehydration, hemoconcentration, repeated microtraumas and extended periods of immobilization during travel or injury. Additionally, the use of combined oral contraceptive (COC) may increases the risk of venous thrombosis fourfold in healthy women. We report a case of a 21-years-old professional female football athlete who developed deep vein thrombosis (DVT) followed by pulmonary embolism (PE). The outpatient hypercoagulability workup was negative and the case was associated to the use of COC pills. The patient was treated with rivaroxaban for 5 months, with complete resolution of the symptoms. There are a few cases in the literature of venous thromboembolism (VTE) involving athletes. Cases of VTE attributable to the use of COC are extremely rare in this population. The diagnosis of VTE in athletes is a challenge for physicians, because the symptoms may erroneously be confused with musculoskeletal complaints. Team physicians who work with female athletes should be alert to modifiable risk factors for VTE, as well as able to perform the early diagnosis and initial clinical management of this condition. DVT should be considered as a differential diagnosis of calf pain in women, especially in athletes, due to the well-defined increase on the risk of thrombosis with the use of COC pills.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.